Proton beam radiation for high-risk prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This trial tests proton radiation therapy for people with high-risk prostate cancer. It may help by delivering radiation in a more targeted way, with the goal of controlling the cancer while reducing exposure to nearby healthy tissue.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have confirmed prostate cancer that is considered “high risk” (based on your biopsy stage or PSA level, or lymph node involvement).
- Your cancer has spread only to the region being treated—not to bones and not to distant lymph nodes—based on scans before treatment.
- You can do daily activities fairly well (performance status 0–2).
- Your recent blood tests are high enough: neutrophils ≥ 1,500, platelets ≥ 100,000, and hemoglobin ≥ 8.0.
- You can sign the study consent form and follow the study plan.
- You have not had certain prior treatments that conflict with this radiation plan (no prior prostate surgery like prostatectomy or overlapping prostate radiation).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a combination of two radiation types—high-dose-rate brachytherapy and stereotactic body radiotherapy—to treat certain intermediate- to high-risk prostate cancers. It may help by aiming radiation closely at the prostate while also targeting the cancer from outside the body.
This trial tests whether giving a short course of hormone therapy (apalutamide) along with targeted, high-dose radiation (SBRT) is safe and effective for men with a specific type of intermediate-risk prostate cancer. You may benefit if you fit the exact risk and test criteria.
This trial tests whether giving a higher dose of radiation therapy (called SBRT) can safely and effectively treat high-risk prostate cancer that hasn't spread. It's for men who have not yet been treated for their cancer.
This trial tests radiation therapy for men with very high-risk prostate cancer that hasn't spread. It aims to see if targeting the tumor with radiation can help control the cancer in this highest risk group.
This study tests a stronger, focused radiation plan for intermediate to higher-risk prostate cancer. It combines a high-dose internal radiation “boost” with external radiation to try to improve cancer control while keeping side effects manageable.
This trial tests a focused form of radiation placed inside the prostate to treat only the cancer area in people with low-risk prostate cancer. It aims to control the cancer while limiting treatment to a smaller area.
Hear when a new Stage III Prostate Cancer AJCC v8 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.